Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS)

Analytical and Bioanalytical Chemistry

Volumn 402, Issue 6, 2012, Pages 2131-2139

  Nguyen, Tam T T N ^a   Østergaard, Jesper ^a   Stürup, Stefan ^a   Gammelgaard, Bente ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Capillary electrophoresis; CE ICP MS; Oxaliplatin; PEGylated liposomes; Phospholipase A 2; Sonication

Indexed keywords

ARGON GAS; CE-ICP-MS; COLLISION GAS; COUPLED PLASMA; DETECTION LIMITS; DRUG FORMULATIONS; DRUG RELEASE; DRUG SUBSTANCES; IN-VITRO; LIPOSOMAL FORMULATION; MICROWAVE DIGESTION; MODEL DRUGS; OXALIPLATIN; PEGYLATED LIPOSOMES; PHOSPHOLIPASE A; SIMULTANEOUS DETERMINATIONS;

ARGON; CAPILLARY ELECTROPHORESIS; DIALYSIS; LIPOSOMES; MASS SPECTROMETERS; PHOSPHOLIPIDS; PHOSPHORUS; PLATINUM; QUALITY ASSURANCE; SONICATION;

INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY;

ANTINEOPLASTIC AGENT; LIPOSOME; OXALIPLATIN; PHOSPHORUS; PLATINUM; PLATINUM COMPLEX;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMISTRY; EVALUATION; MASS SPECTROMETRY; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ANTINEOPLASTIC AGENTS; ELECTROPHORESIS, CAPILLARY; LIPOSOMES; MASS SPECTROMETRY; ORGANOPLATINUM COMPOUNDS; PHOSPHORUS; PLATINUM; SENSITIVITY AND SPECIFICITY;

EID: 84858709083     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5651-6     Document Type: Article

References (25)

1. B Rosenberg L Vancamp T Krigas 1965 Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode Nature 205 698 699 10.1038/205698a0 1:CAS:528:DyaF2MXns1aruw%3D%3D
2. AM Di Francesco A Ruggiero R Riccardi 2002 Cellular and molecular aspects of drugs of the future: oxaliplatin Cell Mol Life Sci 59 1914 1927 10.1007/PL00012514 (Pubitemid 36015864)
3. M Ranson A Howell S Cheeseman J Margison 1996 Liposomal drug delivery Cancer Treat Rev 22 365 379 10.1016/S0305-7372(96)90009-2 1:CAS:528: DyaK2sXisVeiurg%3D (Pubitemid 27138347)
4. VP Torchilin 2005 Recent advances with liposomes as pharmaceutical carriers Nat Rev Drug Discov 4 145 160 10.1038/nrd1632 1:CAS:528: DC%2BD2MXpt1WlsA%3D%3D (Pubitemid 40282557)
5. AK Iyer G Khaled J Fang H Maeda 2006 Exploiting the enhanced permeability and retention effect for tumor targeting Drug Discov Today 11 812 818 10.1016/j.drudis.2006.07.005 1:CAS:528:DC%2BD28XoslOgtLo%3D (Pubitemid 44280021)
6. JM Metselaar E Mastrobattista G Storm 2002 Liposomes for intravenous drug targeting: design and applications Mini Rev Med Chem 2 319 329 10.2174/1389557023405873 1:CAS:528:DC%2BD38XltlCqsLw%3D
7. TL Andresen SS Jensen K Jorgensen 2005 Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog Lipid Res 44 68 97 10.1016/j.plipres.2004.12.001 1:CAS:528: DC%2BD2MXhvVCjtb8%3D (Pubitemid 40313220)
8. A Gomez-Hens JM Fernandez-Romero 2006 Analytical methods for the control of liposomal delivery systems Trac-Trends Anal Chem 25 167 178 10.1016/j.trac.2005.07.006 1:CAS:528:DC%2BD28XhtFyju7w%3D (Pubitemid 43152038)
9. Torchilin VP, Weissig V (2003) Liposomes. A practical approach. Oxford University, New York
10. TTNN Tam S Sturup J Ostergaard U Franzen B Gammelgaard 2011 Simultaneous measurement of phosphorus and platinum by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry (SEC-ICPMS) using xenon as reactive collision gas for characterization of platinum drug liposomes J Anal At Spectrom 26 1466 1473 10.1039/c0ja00266f
11. U Franzen TTTN Nguyen C Vermehren B Gammelgaard J Ostergaard 2011 Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage J Pharmaceut Biomed Anal 55 16 22 10.1016/j.jpba.2010.12.037 1:CAS:528:DC%2BC3MXisFyqtrk%3D
12. SS Kannamkumarath K Wrobel K Wrobel C B'Hymer JA Caruso 2002 Capillary electrophoresis-inductively coupled plasma-mass spectrometry: an attractive complementary technique for elemental speciation analysis J Chromatogr A 975 245 266 10.1016/S0021-9673(02)01218-9 1:CAS:528:DC%2BD38XnvVOitbw%3D
13. XB Yin Y Li XP Yan 2008 CE-ICP-MS for studying interactions between metals and biomolecules Trac-Trends Anal Chem 27 554 565 10.1016/j.trac.2008.04. 003 1:CAS:528:DC%2BD1cXotFCit7k%3D
14. D Profrock P Leonhard A Prange 2003 Determination of phosphorus in phosphorylated deoxyribonucleotides using capillary electrophoresis and high performance liquid chromatography hyphenated to inductively coupled plasma mass spectrometry with an octopoles J Anal At Spectrom 18 708 713 10.1039/b302445h
15. S Fujii K Inagaki K Chiba A Takatsu 2010 Quantification of phosphorus in DNA using capillary electrophoresis hyphenated with inductively coupled plasma mass spectrometry J Chromatogr A 1217 7921 7925 10.1016/j.chroma.2010.10.066 1:CAS:528:DC%2BC3cXhsVGrs7%2FJ
16. B Michalke 2005 Capillary electrophoresis-inductively coupled plasma-mass spectrometry: a report on technical principles and problem solutions, potential, and limitations of this technology as well as on examples of application Electrophoresis 26 1584 1597 10.1002/elps.200410314 1:CAS:528:DC%2BD2MXktVSqt7c%3D (Pubitemid 40645477)
17. TL Andresen SS Jensen T Kaasgaard K Jorgensen 2005 Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2 Curr Drug Deliv 2 353 362 10.2174/156720105774370203 1:CAS:528:DC%2BD2MXhtVSkt7%2FF (Pubitemid 41277767)
18. TL Andresen DH Thompson T Kaasgaard 2010 Enzyme-triggered nanomedicine: drug release strategies in cancer therapy (invited review) Mol Membr Biol 27 353 363 10.3109/09687688.2010.515950 1:CAS:528:DC%2BC3cXhtlCltLfE
19. J Davidsen K Jorgensen TL Andresen OG Mouritsen 2003 Secreted phospholipase A(2) as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue Biochim Biophys Acta 1609 95 101 10.1016/S0005-2736(02)00659-4 1:CAS:528:DC%2BD38XpvVaisLg%3D (Pubitemid 36044070)
20. T Abe K Sakamoto H Kamohara Y Hirano N Kuwahara M Ogawa 1997 Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer Int J Cancer 74 245 250 10.1002/(SICI)1097- 0215(19970620)74:3<245::AID-IJC2>3.0.CO;2-Z 1:STN:280:DyaK2szmsVymsg%3D%3D (Pubitemid 27321790)
21. Z Ying H Tojo T Komatsubara M Nakagawa M Inada S Kawata Y Matsuzawa M Okamoto 1994 Enhanced expression of group-Ii phospholipase A(2) in human hepatocellular-carcinoma Biochim Biophys Acta-Mol Basis Dis 1226 201 205 1:CAS:528:DyaK2cXktlaiu7k%3D (Pubitemid 24182465)
22. Vikbjerg AF, Petersen SA [DK], Melander F [SE], Henriksen JR [DK], Joergensen K [DK] (2009) Liposomes for drug delivery and methods for preparation thereof. WO2009EP56297 20090525 [WO2009141450 (A2)]. Ref Type: Patent
23. C Moller S Sturup HR Hansen B Gammelgaard 2009 Comparison of two CE-ICP-MS interfaces and quantitative measurements of carboplatin in plasma samples using an internal standard J Anal At Spectrom 24 1208 1212 10.1039/b822857d
24. B Michalke P Schramel 1997 Coupling of capillary electrophoresis with ICP-MS for speciation investigations Fresenius J Anal Chem 357 594 599 10.1007/s002160050220 1:CAS:528:DyaK2sXisVerurk%3D (Pubitemid 127713800)
25. J Balsinde MA Balboa PA Insel EA Dennis 1999 Regulation and inhibition of phospholipase A(2) Annu Rev Pharmacol Toxicol 39 175 189 10.1146/annurev. pharmtox.39.1.175 1:CAS:528:DyaK1MXjtVejt7g%3D (Pubitemid 29222556)